🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the safety of the Leish-111f + MPL-SE vaccine in a...
Status
Completed
Location
Universidade Federal de Minas Gerais
Start Date
2004-10
Trial ID
NCT00111553
Treatments Being Tested
The purpose of this study is to evaluate the safety of the Leish-111f + MPL...
Status
Completed
Location
Clínica de Leishmaniasis, Hospital Nacional Sur Este EsSalud
Start Date
2004-07
Trial ID
NCT00111514
Treatments Being Tested
A phase 1, randomized, double-blind, placebo-controlled study to evaluate t...
Status
Completed
Location
IEND
Start Date
2009-04
Trial ID
NCT00982774
Treatments Being Tested
The purpose of this study is to determine if a vaccine (called Leish-111f +...
Status
Completed
Location
Banaras Hindu University
Start Date
2007-04
Trial ID
NCT00486382
Treatments Being Tested
The purpose of this study is to determine the efficacy, safety, and immunog...
Status
Completed
Location
Instituto de Medicina Tropical"Alexander von Humboldt"
Start Date
2009-10
Trial ID
NCT01011309
Treatments Being Tested
This study will evaluate the safety and immunogenicity of the Leish-111f + ...
Status
Completed
Location
Programa de Estudio y Control de Enfermedades Tropicales (PECET)
Start Date
2005-08
Trial ID
NCT00121862
Treatments Being Tested
Investigational products: LEISH-F3 (recombinant protein antigen) + GLA-SE (...
Status
Completed
Location
University of Iowa - Vaccine Research and Education Unit
Start Date
2013-03
Trial ID
NCT01751048
This study will evaluate the safety of the Leish-111f + MPL-SE vaccine in a...
Status
Completed
Location
Programa de Estudio y Control de Enfermedades Tropicales (PECET)
Start Date
2005-08
Trial ID
NCT00121849
Treatments Being Tested